ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 177 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q4 2016. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $7,000 | -36.4% | 94 | -20.3% | 0.00% | – |
Q3 2021 | $11,000 | 0.0% | 118 | 0.0% | 0.00% | – |
Q2 2021 | $11,000 | -75.6% | 118 | -70.5% | 0.00% | – |
Q1 2021 | $45,000 | -97.6% | 400 | -98.3% | 0.00% | -100.0% |
Q2 2020 | $1,844,000 | +171.6% | 23,579 | +54.3% | 0.00% | +200.0% |
Q1 2020 | $679,000 | +24.6% | 15,285 | +19.7% | 0.00% | 0.0% |
Q4 2019 | $545,000 | +14.7% | 12,772 | +14.9% | 0.00% | 0.0% |
Q3 2019 | $475,000 | +90.8% | 11,113 | +209.3% | 0.00% | 0.0% |
Q1 2019 | $249,000 | +295.2% | 3,593 | +332.4% | 0.00% | – |
Q3 2018 | $63,000 | -54.0% | 831 | -69.2% | 0.00% | -100.0% |
Q1 2018 | $137,000 | +53.9% | 2,696 | +87.1% | 0.01% | +50.0% |
Q2 2017 | $89,000 | -83.4% | 1,441 | -81.8% | 0.00% | -82.6% |
Q1 2017 | $535,000 | +5.7% | 7,898 | +9.7% | 0.02% | -23.3% |
Q4 2016 | $506,000 | +173.5% | 7,198 | +174.9% | 0.03% | +130.8% |
Q3 2016 | $185,000 | +224.6% | 2,618 | +124.3% | 0.01% | +225.0% |
Q2 2016 | $57,000 | – | 1,167 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Iguana Healthcare Management, LLC | 75,000 | $5,084,000 | 2.52% |
COLUMBIA WANGER ASSET MANAGEMENT LLC | 1,237,825 | $83,900,000 | 1.18% |
CAPITAL INTERNATIONAL LTD /CA/ | 206,718 | $14,011,000 | 0.91% |
Cormorant Asset Management, LP | 75,000 | $5,084,000 | 0.74% |
Capital International Sarl | 107,450 | $7,283,000 | 0.63% |
Rock Springs Capital Management LP | 159,750 | $10,828,000 | 0.62% |
Opus Point Partners Management, LLC | 12,201 | $827,000 | 0.61% |
Hood River Capital Management LLC | 109,629 | $7,431,000 | 0.56% |
Aureus Asset Management, LLC | 50,740 | $2,927,000 | 0.51% |
ROCKEFELLER FINANCIAL SERVICES INC | 374,663 | $25,395,000 | 0.51% |